Active 0 6 0 6 B-chronic_disease
or 7 9 7 9 I-chronic_disease
symptomatic 10 21 10 21 I-chronic_disease
viral 22 27 22 27 I-chronic_disease
hepatitis 28 37 28 37 I-chronic_disease
or 38 40 38 40 O
chronic 41 48 41 48 O
liver 49 54 49 54 O
disease 55 62 55 62 O

Adequately 0 10 63 73 O
treated 11 18 74 81 O
basal 19 24 82 87 B-cancer
cell 25 29 88 92 I-cancer
or 30 32 93 95 O
squamous 33 41 96 104 B-cancer
cell 42 46 105 109 I-cancer
skin 47 51 110 114 I-cancer
cancer 52 58 115 121 I-cancer

Administration 0 14 122 136 O
of 15 17 137 139 O
an 18 20 140 142 O
investigational 21 36 143 158 B-treatment
therapeutic 37 48 159 170 I-treatment
within 49 55 171 177 O
30 56 58 178 180 B-upper_bound
days 59 63 181 185 I-upper_bound
of 64 66 186 188 O
cycle 67 72 189 194 O
1 73 74 195 196 O
, 74 75 196 197 O
day 76 79 198 201 O
-2 80 82 202 204 O

Agree 0 5 205 210 O
to 6 8 211 213 O
participate 9 20 214 225 O
in 21 23 226 228 O
biopsy 24 30 229 235 B-treatment
of 31 33 236 238 I-treatment
metastatic 34 44 239 249 I-treatment
lesion 45 51 250 256 I-treatment
during 52 58 257 263 O
the 59 62 264 267 O
study 63 68 268 273 O
at 69 71 274 276 O
day 72 75 277 280 O
21 76 78 281 283 O

Atrial 0 6 284 290 B-chronic_disease
fibrillation 7 19 291 303 I-chronic_disease
, 19 20 303 304 O
or 21 23 305 307 O
other 24 29 308 313 O
cardiac 30 37 314 321 B-chronic_disease
arrhythmia 38 48 322 332 I-chronic_disease
requiring 49 58 333 342 O
medical 59 66 343 350 O
therapy 67 74 351 358 B-treatment

Castration 0 10 359 369 B-cancer
resistant 11 20 370 379 I-cancer
prostate 21 29 380 388 I-cancer
cancer 30 36 389 395 I-cancer
as 37 39 396 398 O
defined 40 47 399 406 O
by 48 50 407 409 O
serum 51 56 410 415 B-clinical_variable
testosterone 57 69 416 428 I-clinical_variable
< 70 71 429 430 O
50 72 74 431 433 B-upper_bound
ng 75 77 434 436 I-upper_bound
/ 77 78 436 437 I-upper_bound
ml 78 80 437 439 I-upper_bound

Clinically 0 10 440 450 O
significant 11 22 451 462 O
heart 23 28 463 468 B-chronic_disease
disease 29 36 469 476 I-chronic_disease
as 37 39 477 479 O
evidenced 40 49 480 489 O
by 50 52 490 492 O
myocardial 53 63 493 503 B-chronic_disease
infarction 64 74 504 514 I-chronic_disease
, 74 75 514 515 O
or 76 78 516 518 O
arterial 79 87 519 527 B-chronic_disease
thrombotic 88 98 528 538 I-chronic_disease
events 99 105 539 545 I-chronic_disease
in 106 108 546 548 O
the 109 112 549 552 O
past 113 117 553 557 B-upper_bound
6 118 119 558 559 I-upper_bound
months 120 126 560 566 I-upper_bound
, 126 127 566 567 O
severe 128 134 568 574 B-chronic_disease
or 135 137 575 577 I-chronic_disease
unstable 138 146 578 586 I-chronic_disease
angina 147 153 587 593 I-chronic_disease
, 153 154 593 594 O
or 155 157 595 597 O
New 158 161 598 601 B-clinical_variable
York 162 166 602 606 I-clinical_variable
Heart 167 172 607 612 I-clinical_variable
Association 173 184 613 624 I-clinical_variable
( 185 186 625 626 I-clinical_variable
NYHA 186 190 626 630 I-clinical_variable
) 190 191 630 631 I-clinical_variable
class 192 197 632 637 I-clinical_variable
II 198 200 638 640 B-lower_bound
- 200 201 640 641 O
IV 201 203 641 643 B-upper_bound
heart 204 209 644 649 O
disease 210 217 650 657 O

Eastern 0 7 658 665 B-clinical_variable
Cooperative 8 19 666 677 I-clinical_variable
Oncology 20 28 678 686 I-clinical_variable
Group 29 34 687 692 I-clinical_variable
( 35 36 693 694 I-clinical_variable
ECOG 36 40 694 698 I-clinical_variable
) 40 41 698 699 I-clinical_variable
performance 42 53 700 711 I-clinical_variable
status 54 60 712 718 I-clinical_variable
of 61 63 719 721 O
= 64 65 722 723 O
< 65 66 723 724 O
1 67 68 725 726 B-upper_bound

Estimated 0 9 727 736 B-clinical_variable
creatinine 10 20 737 747 I-clinical_variable
clearance 21 30 748 757 I-clinical_variable
less 31 35 758 762 O
than 36 40 763 767 O
50 41 43 768 770 B-upper_bound
ml 44 46 771 773 I-upper_bound
/ 46 47 773 774 I-upper_bound
minute 47 53 774 780 I-upper_bound

Histologically 0 14 781 795 O
or 15 17 796 798 O
cytologically 18 31 799 812 O
confirmed 32 41 813 822 O
carcinoma 42 51 823 832 B-cancer
of 52 54 833 835 I-cancer
the 55 58 836 839 I-cancer
prostate 59 67 840 848 I-cancer

In 0 2 849 851 O
situ 3 7 852 856 B-cancer
carcinoma 8 17 857 866 I-cancer
of 18 20 867 869 O
any 21 24 870 873 O
site 25 29 874 878 O

Known 0 5 879 884 O
parenchymal 6 17 885 896 B-cancer
brain 18 23 897 902 I-cancer
metastasis 24 34 903 913 I-cancer

Life 0 4 914 918 B-clinical_variable
expectancy 5 15 919 929 I-clinical_variable
> 16 17 930 931 O
= 17 18 931 932 O
12 19 21 933 935 B-lower_bound
weeks 22 27 936 941 I-lower_bound

No 0 2 942 944 O
prior 3 8 945 950 O
malignancy 9 19 951 961 B-cancer

Ongoing 0 7 962 969 O
gonadal 8 15 970 977 B-treatment
androgen 16 24 978 986 I-treatment
deprivation 25 36 987 998 I-treatment
therapy 37 44 999 1006 I-treatment
with 45 49 1007 1011 I-treatment
gonadotropin 50 62 1012 1024 I-treatment
- 62 63 1024 1025 I-treatment
releasing 63 72 1025 1034 I-treatment
hormone 73 80 1035 1042 I-treatment
( 81 82 1043 1044 I-treatment
GnRH 82 86 1044 1048 I-treatment
) 86 87 1048 1049 I-treatment
analogues 88 97 1050 1059 I-treatment
, 97 98 1059 1060 O
antagonists 99 110 1061 1072 B-treatment
or 111 113 1073 1075 O
orchiectomy 114 125 1076 1087 B-treatment

Other 0 5 1088 1093 O
adequately 6 16 1094 1104 O
treated 17 24 1105 1112 O
malignancy 25 35 1113 1123 B-cancer
for 36 39 1124 1127 O
which 40 45 1128 1133 O
the 46 49 1134 1137 O
patient 50 57 1138 1145 O
is 58 60 1146 1148 O
currently 61 70 1149 1158 O
disease 71 78 1159 1166 O
free 79 83 1167 1171 O
for 84 87 1172 1175 O
at 88 90 1176 1178 O
least 91 96 1179 1184 O
one 97 100 1185 1188 B-lower_bound
year 101 105 1189 1193 I-lower_bound

PSA 0 3 1194 1197 B-clinical_variable
level 4 9 1198 1203 I-clinical_variable
of 10 12 1204 1206 O
at 13 15 1207 1209 O
least 16 21 1210 1215 O
2 22 23 1216 1217 B-lower_bound
ng 24 26 1218 1220 I-lower_bound
/ 26 27 1220 1221 I-lower_bound
ml 27 29 1221 1223 I-lower_bound
that 30 34 1224 1228 O
has 35 38 1229 1232 O
risen 39 44 1233 1238 O
on 45 47 1239 1241 O
at 48 50 1242 1244 O
least 51 56 1245 1250 O
2 57 58 1251 1252 O
successive 59 69 1253 1263 O
occasions 70 79 1264 1273 O
at 80 82 1274 1276 O
least 83 88 1277 1282 O
1 89 90 1283 1284 B-lower_bound
week 91 95 1285 1289 I-lower_bound
apart 96 101 1290 1295 O

Patients 0 8 1296 1304 O
currently 9 18 1305 1314 O
receiving 19 28 1315 1324 O
active 29 35 1325 1331 O
therapy 36 43 1332 1339 B-treatment
for 44 47 1340 1343 O
other 48 53 1344 1349 O
neoplastic 54 64 1350 1360 B-chronic_disease
disorders 65 74 1361 1370 I-chronic_disease

Patients 0 8 1371 1379 O
on 9 11 1380 1382 O
anticoagulation 12 27 1383 1398 B-treatment
therapy 28 35 1399 1406 I-treatment
which 36 41 1407 1412 O
can 42 45 1413 1416 O
not 45 48 1416 1419 O
be 49 51 1420 1422 O
held 52 56 1423 1427 O
for 57 60 1428 1431 O
metastatic 61 71 1432 1442 B-treatment
biopsies 72 80 1443 1451 I-treatment

Patients 0 8 1452 1460 O
who 9 12 1461 1464 O
are 13 16 1465 1468 O
or 17 19 1469 1471 O
are 20 23 1472 1475 O
not 24 27 1476 1479 O
receiving 28 37 1480 1489 O
bisphosphonates 38 53 1490 1505 B-treatment
or 54 56 1506 1508 O
denosumab 57 66 1509 1518 B-treatment

Patients 0 8 1519 1527 O
with 9 13 1528 1532 O
any 14 17 1533 1536 O
prior 18 23 1537 1542 B-treatment
chemotherapy 24 36 1543 1555 I-treatment
regimens 37 45 1556 1564 I-treatment

Patients 0 8 1565 1573 O
with 9 13 1574 1578 O
dementia 14 22 1579 1587 B-chronic_disease
/ 22 23 1587 1588 O
psychiatric 23 34 1588 1599 B-chronic_disease
illness 35 42 1600 1607 I-chronic_disease
/ 42 43 1607 1608 I-chronic_disease
social 43 49 1608 1614 I-chronic_disease
situations 50 60 1615 1625 I-chronic_disease
that 61 65 1626 1630 O
would 66 71 1631 1636 O
limit 72 77 1637 1642 O
compliance 78 88 1643 1653 O
with 89 93 1654 1658 O
study 94 99 1659 1664 O
requirements 100 112 1665 1677 O
or 113 115 1678 1680 O
would 116 121 1681 1686 O
prohibit 122 130 1687 1695 O
the 131 134 1696 1699 O
understanding 135 148 1700 1713 O
and/or 149 155 1714 1720 O
giving 156 162 1721 1727 O
of 163 165 1728 1730 O
informed 166 174 1731 1739 O
consent 175 182 1740 1747 O

Patients 0 8 1748 1756 O
with 9 13 1757 1761 O
disease 14 21 1762 1769 O
only 22 26 1770 1774 O
in 27 29 1775 1777 O
the 30 33 1778 1781 O
bone 34 38 1782 1786 O
may 39 42 1787 1790 O
not 43 46 1791 1794 O
have 47 51 1795 1799 O
received 52 60 1800 1808 O
Xofigo 61 67 1809 1815 B-treatment
/ 67 68 1815 1816 I-treatment
radium 68 74 1816 1822 I-treatment
223 75 78 1823 1826 I-treatment
to 79 81 1827 1829 O
avoid 82 87 1830 1835 O
ongoing 88 95 1836 1843 O
DNA 96 99 1844 1847 O
damage 100 106 1848 1854 O
in 107 109 1855 1857 O
bone 110 114 1858 1862 O
marrow 115 121 1863 1869 O

Patients 0 8 1870 1878 O
with 9 13 1879 1883 O
disease 14 21 1884 1891 O
only 22 26 1892 1896 O
in 27 29 1897 1899 O
the 30 33 1900 1903 O
bone 34 38 1904 1908 O
previously 39 49 1909 1919 O
treated 50 57 1920 1927 O
with 58 62 1928 1932 O
radium-223 63 73 1933 1943 B-treatment
will 74 78 1944 1948 O
not 79 82 1949 1952 O
be 83 85 1953 1955 O
eligible 86 94 1956 1964 O

Patients 0 8 1965 1973 O
with 9 13 1974 1978 O
histologic 14 24 1979 1989 O
evidence 25 33 1990 1998 O
of 34 36 1999 2001 O
small 37 42 2002 2007 B-cancer
cell 43 47 2008 2012 I-cancer
carcinoma 48 57 2013 2022 I-cancer
of 58 60 2023 2025 I-cancer
the 61 64 2026 2029 I-cancer
prostate 65 73 2030 2038 I-cancer
will 74 78 2039 2043 O
not 79 82 2044 2047 O
be 83 85 2048 2050 O
eligible 86 94 2051 2059 O

Patients 0 8 2060 2068 O
with 9 13 2069 2073 O
medical 14 21 2074 2081 B-chronic_disease
conditions 22 32 2082 2092 I-chronic_disease
, 32 33 2092 2093 O
which 34 39 2094 2099 O
, 39 40 2099 2100 O
in 41 43 2101 2103 O
the 44 47 2104 2107 O
opinion 48 55 2108 2115 O
of 56 58 2116 2118 O
the 59 62 2119 2122 O
investigators 63 76 2123 2136 O
, 76 77 2136 2137 O
would 78 83 2138 2143 O
jeopardize 84 94 2144 2154 O
either 95 101 2155 2161 O
the 102 105 2162 2165 O
patient 106 113 2166 2173 O
or 114 116 2174 2176 O
the 117 120 2177 2180 O
integrity 121 130 2181 2190 O
of 131 133 2191 2193 O
the 134 137 2194 2197 O
data 138 142 2198 2202 O
obtained 143 151 2203 2211 O

Prior 0 5 2212 2217 B-treatment
therapy 6 13 2218 2225 I-treatment
with 14 18 2226 2230 O
abiraterone 19 30 2231 2242 B-treatment
, 30 31 2242 2243 O
enzalutamide 32 44 2244 2256 B-treatment
and/or 45 51 2257 2263 O
docetaxel 52 61 2264 2273 B-treatment

Progression 0 11 2274 2285 O
of 12 14 2286 2288 O
metastatic 15 25 2289 2299 B-cancer
bone 26 30 2300 2304 I-cancer
disease 31 38 2305 2312 I-cancer
on 39 41 2313 2315 O
bone 42 46 2316 2320 B-treatment
scan 47 51 2321 2325 I-treatment
with 52 56 2326 2330 O
> 57 58 2331 2332 O
2 59 60 2333 2334 B-lower_bound
new 61 64 2335 2338 O
lesions 65 72 2339 2346 O

The 0 3 2347 2350 O
presence 4 12 2351 2359 O
of 13 15 2360 2362 O
metastatic 16 26 2363 2373 B-cancer
disease 27 34 2374 2381 I-cancer
amenable 35 43 2382 2390 O
to 44 46 2391 2393 O
computed 47 55 2394 2402 B-treatment
tomography 56 66 2403 2413 I-treatment
( 67 68 2414 2415 I-treatment
CT 68 70 2415 2417 I-treatment
) 70 71 2417 2418 I-treatment
or 72 74 2419 2421 O
ultrasound 75 85 2422 2432 B-treatment
guided 86 92 2433 2439 I-treatment
biopsy 93 99 2440 2446 I-treatment
; 99 100 2446 2447 O
this 101 105 2448 2452 O
may 106 109 2453 2456 O
include 110 117 2457 2464 O
thoracolumbar 118 131 2465 2478 B-cancer
vertebral 132 141 2479 2488 I-cancer
bodies 142 148 2489 2495 I-cancer
, 148 149 2495 2496 O
pelvis 150 156 2497 2503 B-cancer
, 156 157 2503 2504 O
femur 158 163 2505 2510 B-cancer
or 164 166 2511 2513 O
humerus 167 174 2514 2521 B-cancer
or 175 177 2522 2524 O
soft 178 182 2525 2529 B-cancer
tissue 183 189 2530 2536 I-cancer
or 190 192 2537 2539 O
nodal 193 198 2540 2545 B-cancer
metastasis 199 209 2546 2556 I-cancer
amenable 210 218 2557 2565 O
to 219 221 2566 2568 O
biopsy 222 228 2569 2575 O

Within 0 6 2576 2582 O
14 7 9 2583 2585 B-upper_bound
days 10 14 2586 2590 I-upper_bound
prior 15 20 2591 2596 I-upper_bound
to 21 23 2597 2599 O
registration 24 36 2600 2612 O
: 36 37 2612 2613 O
Absolute 38 46 2614 2622 B-clinical_variable
neutrophil 47 57 2623 2633 I-clinical_variable
count 58 63 2634 2639 I-clinical_variable
> 64 65 2640 2641 O
= 65 66 2641 2642 O
1.5 67 70 2643 2646 B-lower_bound
x 71 72 2647 2648 I-lower_bound
10 73 75 2649 2651 I-lower_bound
^ 75 76 2651 2652 I-lower_bound
9 76 77 2652 2653 I-lower_bound
cells 78 83 2654 2659 I-lower_bound
/ 83 84 2659 2660 I-lower_bound
L 84 85 2660 2661 I-lower_bound

Within 0 6 2662 2668 O
14 7 9 2669 2671 B-upper_bound
days 10 14 2672 2676 I-upper_bound
prior 15 20 2677 2682 I-upper_bound
to 21 23 2683 2685 O
registration 24 36 2686 2698 O
: 36 37 2698 2699 O
Aspartate 38 47 2700 2709 B-clinical_variable
aminotransferase 48 64 2710 2726 I-clinical_variable
( 65 66 2727 2728 I-clinical_variable
AST 66 69 2728 2731 I-clinical_variable
) 69 70 2731 2732 I-clinical_variable
and 71 74 2733 2736 O
alanine 75 82 2737 2744 B-clinical_variable
aminotransferase 83 99 2745 2761 I-clinical_variable
( 100 101 2762 2763 I-clinical_variable
ALT 101 104 2763 2766 I-clinical_variable
) 104 105 2766 2767 I-clinical_variable
= 106 107 2768 2769 O
< 107 108 2769 2770 O
1.5 109 112 2771 2774 B-upper_bound
x 113 114 2775 2776 I-upper_bound
upper 115 120 2777 2782 I-upper_bound
limit 121 126 2783 2788 I-upper_bound
of 127 129 2789 2791 I-upper_bound
normal 130 136 2792 2798 I-upper_bound
( 137 138 2799 2800 I-upper_bound
ULN 138 141 2800 2803 I-upper_bound
) 141 142 2803 2804 I-upper_bound

Within 0 6 2805 2811 O
14 7 9 2812 2814 B-upper_bound
days 10 14 2815 2819 I-upper_bound
prior 15 20 2820 2825 I-upper_bound
to 21 23 2826 2828 O
registration 24 36 2829 2841 O
: 36 37 2841 2842 O
Hemoglobin 38 48 2843 2853 B-clinical_variable
( 49 50 2854 2855 I-clinical_variable
Hgb 50 53 2855 2858 I-clinical_variable
) 53 54 2858 2859 I-clinical_variable
> 55 56 2860 2861 O
= 56 57 2861 2862 O
9.0 58 61 2863 2866 B-lower_bound
g 62 63 2867 2868 I-lower_bound
/ 63 64 2868 2869 I-lower_bound
dL 64 66 2869 2871 I-lower_bound

Within 0 6 2872 2878 O
14 7 9 2879 2881 B-upper_bound
days 10 14 2882 2886 I-upper_bound
prior 15 20 2887 2892 I-upper_bound
to 21 23 2893 2895 O
registration 24 36 2896 2908 O
: 36 37 2908 2909 O
Platelets 38 47 2910 2919 B-clinical_variable
> 48 49 2920 2921 O
= 49 50 2921 2922 O
100,000 51 58 2923 2930 B-lower_bound
x 59 60 2931 2932 I-lower_bound
10 61 63 2933 2935 I-lower_bound
^ 63 64 2935 2936 I-lower_bound
9 64 65 2936 2937 I-lower_bound
/ 65 66 2937 2938 I-lower_bound
L 66 67 2938 2939 I-lower_bound

Within 0 6 2940 2946 O
14 7 9 2947 2949 B-upper_bound
days 10 14 2950 2954 I-upper_bound
prior 15 20 2955 2960 I-upper_bound
to 21 23 2961 2963 O
registration 24 36 2964 2976 O
: 36 37 2976 2977 O
Serum 38 43 2978 2983 B-clinical_variable
creatinine 44 54 2984 2994 I-clinical_variable
< 55 56 2995 2996 O
1.5 57 60 2997 3000 B-upper_bound
X 61 62 3001 3002 I-upper_bound
institutional 63 76 3003 3016 I-upper_bound
ULN 77 80 3017 3020 I-upper_bound
mg 81 83 3021 3023 I-upper_bound
/ 83 84 3023 3024 I-upper_bound
dL 84 86 3024 3026 I-upper_bound
OR 87 89 3027 3029 O
estimated 90 99 3030 3039 B-clinical_variable
glomerular 100 110 3040 3050 I-clinical_variable
filtration 111 121 3051 3061 I-clinical_variable
rate 122 126 3062 3066 I-clinical_variable
( 127 128 3067 3068 I-clinical_variable
eGFR 128 132 3068 3072 I-clinical_variable
) 132 133 3072 3073 I-clinical_variable
> 134 135 3074 3075 O
= 135 136 3075 3076 O
50 137 139 3077 3079 B-lower_bound
mL 140 142 3080 3082 I-lower_bound
/ 142 143 3082 3083 I-lower_bound
min 143 146 3083 3086 I-lower_bound

Within 0 6 3087 3093 O
14 7 9 3094 3096 B-upper_bound
days 10 14 3097 3101 I-upper_bound
prior 15 20 3102 3107 I-upper_bound
to 21 23 3108 3110 O
registration 24 36 3111 3123 O
: 36 37 3123 3124 O
Total 38 43 3125 3130 B-clinical_variable
bilirubin 44 53 3131 3140 I-clinical_variable
= 54 55 3141 3142 O
< 55 56 3142 3143 O
1.5 57 60 3144 3147 B-upper_bound
x 61 62 3148 3149 I-upper_bound
ULN 63 66 3150 3153 I-upper_bound

bisphosphonates 0 15 3154 3169 B-treatment
or 16 18 3170 3172 O
denosumab 19 28 3173 3182 B-treatment
should 29 35 3183 3189 O
not 36 39 3190 3193 O
be 40 42 3194 3196 O
initiated 43 52 3197 3206 O
after 53 58 3207 3212 O
registration 59 71 3213 3225 O
and 72 75 3226 3229 O
during 76 82 3230 3236 O
active 83 89 3237 3243 O
treatment 90 99 3244 3253 B-treatment

neuroendocrine 0 14 3254 3268 B-cancer
differentiation 15 30 3269 3284 I-cancer

patient 0 7 3285 3292 O
must 8 12 3293 3297 O
be 13 15 3298 3300 O
offered 16 23 3301 3308 O
and 24 27 3309 3312 O
made 28 32 3313 3317 O
aware 33 38 3318 3323 O
of 39 41 3324 3326 O
all 42 45 3327 3330 O
Food 46 50 3331 3335 O
and 51 54 3336 3339 O
Drug 55 59 3340 3344 O
Administration 60 74 3345 3359 O
( 75 76 3360 3361 O
FDA)‐approved 76 89 3361 3374 O
treatment 90 99 3375 3384 B-treatment
options 100 107 3385 3392 O
; 107 108 3392 3393 O
patients 109 117 3394 3402 O
with 118 122 3403 3407 O
bone 123 127 3408 3412 B-chronic_disease
only 128 132 3413 3417 I-chronic_disease
disease 133 140 3418 3425 I-chronic_disease
may 141 144 3426 3429 O
not 145 148 3430 3433 O
have 149 153 3434 3438 O
received 154 162 3439 3447 O
radium-223 163 173 3448 3458 B-treatment

patients 0 8 3459 3467 O
who 9 12 3468 3471 O
have 13 17 3472 3476 O
not 18 21 3477 3480 O
had 22 25 3481 3484 O
an 26 28 3485 3487 O
orchiectomy 29 40 3488 3499 B-treatment
must 41 45 3500 3504 O
be 46 48 3505 3507 O
maintained 49 59 3508 3518 O
on 60 62 3519 3521 O
effective 63 72 3522 3531 O
GnRH 73 77 3532 3536 B-treatment
analogue 78 86 3537 3545 I-treatment
/ 86 87 3545 3546 O
antagonist 87 97 3546 3556 B-treatment
therapy 98 105 3557 3564 I-treatment

squamous 0 8 3565 3573 B-cancer
cell 9 13 3574 3578 I-cancer
histology 14 23 3579 3588 O

